184 related articles for article (PubMed ID: 9134044)
21. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions.
Seifert PS; Roth I; Schmiedt W; Oelert H; Okada N; Okada H; Bhakdi S
Atherosclerosis; 1992 Oct; 96(2-3):135-45. PubMed ID: 1281630
[TBL] [Abstract][Full Text] [Related]
22. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer.
Inoue H; Mizuno M; Uesu T; Ueki T; Tsuji T
Acta Med Okayama; 1994 Oct; 48(5):271-7. PubMed ID: 7532345
[TBL] [Abstract][Full Text] [Related]
23. Induced expression of neuronal membrane attack complex and cell death by Alzheimer's beta-amyloid peptide.
Shen Y; Sullivan T; Lee CM; Meri S; Shiosaki K; Lin CW
Brain Res; 1998 Jun; 796(1-2):187-97. PubMed ID: 9689469
[TBL] [Abstract][Full Text] [Related]
24. Unique expression of HRF20 (CD59) in human nervous tissue.
Akatsu H; Yamada T; Okada N; Yamamoto T; Yamashina M; Okada H
Microbiol Immunol; 1997; 41(4):321-9. PubMed ID: 9159406
[TBL] [Abstract][Full Text] [Related]
25. Dynamics and Molecular Interactions of GPI-Anchored CD59.
Voisin TB; Couves EC; Tate EW; Bubeck D
Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505699
[TBL] [Abstract][Full Text] [Related]
26. New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement.
Schnabolk G; Beon MK; Tomlinson S; Rohrer B
J Ocul Pharmacol Ther; 2017 Jun; 33(5):400-411. PubMed ID: 28333572
[TBL] [Abstract][Full Text] [Related]
27. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
28. IgM colocalises with complement and C reactive protein in infarcted human myocardium.
Krijnen PA; Ciurana C; Cramer T; Hazes T; Meijer CJ; Visser CA; Niessen HW; Hack CE
J Clin Pathol; 2005 Apr; 58(4):382-8. PubMed ID: 15790702
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.
Liu F; Sahoo R; Ge X; Wu L; Ghosh P; Qin X; Halperin JA
J Diabetes Complications; 2017 Feb; 31(2):311-317. PubMed ID: 27729184
[TBL] [Abstract][Full Text] [Related]
30. Unveiling CD59-Antibody Interactions to Design Paratope-Mimicking Peptides for Complement Modulation.
Sandomenico A; Ruggiero A; Iaccarino E; Oliver A; Squeglia F; Moreira M; Esposito L; Ruvo M; Berisio R
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239905
[TBL] [Abstract][Full Text] [Related]
31. Enhanced expression of decay-accelerating factor and CD59/homologous restriction factor 20 in intestinal metaplasia, gastric adenomas and intestinal-type gastric carcinomas but not in diffuse-type carcinomas.
Kiso T; Mizuno M; Nasu J; Shimo K; Uesu T; Yamamoto K; Okada H; Fujita T; Tsuji T
Histopathology; 2002 Apr; 40(4):339-47. PubMed ID: 11943018
[TBL] [Abstract][Full Text] [Related]
32. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector.
Hayashi S; Isobe K; Emi N; Yokoyama I; Okada H; Nakashima I; Takagi H
Eur Surg Res; 1996; 28(6):440-6. PubMed ID: 8954321
[TBL] [Abstract][Full Text] [Related]
34. Endovascular trophoblast expresses CD59 to evade complement-dependent cytotoxicity.
Ueda M; Sato Y; Horie A; Tani H; Miyazaki Y; Okunomiya A; Matsumoto H; Hamanishi J; Kondoh E; Mandai M
Mol Cell Endocrinol; 2019 Jun; 490():57-67. PubMed ID: 30981734
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.
Ramo K; Cashman SM; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4126-36. PubMed ID: 18487376
[TBL] [Abstract][Full Text] [Related]
36. 20 KDa homologous restriction factor of complement resembles T cell activating protein.
Okada H; Nagami Y; Takahashi K; Okada N; Hideshima T; Takizawa H; Kondo J
Biochem Biophys Res Commun; 1989 Aug; 162(3):1553-9. PubMed ID: 2475111
[TBL] [Abstract][Full Text] [Related]
37. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59).
Rautemaa R; Meri S
J Dent Res; 1996 Jan; 75(1):568-74. PubMed ID: 8655761
[TBL] [Abstract][Full Text] [Related]
38. Complement activation in acute myocardial infarction: An early marker of inflammation and tissue injury?
Bavia L; Lidani KCF; Andrade FA; Sobrinho MIAH; Nisihara RM; de Messias-Reason IJ
Immunol Lett; 2018 Aug; 200():18-25. PubMed ID: 29908956
[TBL] [Abstract][Full Text] [Related]
39. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo.
Nose M; Katoh M; Okada N; Kyogoku M; Okada H
Immunology; 1990 Jun; 70(2):145-9. PubMed ID: 1695609
[TBL] [Abstract][Full Text] [Related]
40. Human heart generates complement proteins that are upregulated and activated after myocardial infarction.
Yasojima K; Schwab C; McGeer EG; McGeer PL
Circ Res; 1998 Oct; 83(8):860-9. PubMed ID: 9776733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
